1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
DPP-4 inhibition and the path to clinical proof
(
- Contribution to journal › Article
- 2018
-
Mark
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
(
- Contribution to journal › Article
- 2013
-
Mark
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
(
- Contribution to journal › Article
- 2006
-
Mark
Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.
(
- Contribution to journal › Article
- 2005
-
Mark
Alpha cell function in health and disease: influence of glucagon-like peptide-1
(
- Contribution to journal › Scientific review